TESTING CENTERs

TESTING CENTERs, based in Easton, PA, is one of the SAMHSA-registered treatment programs operating in PA. The facility's programming is outpatient (IOP, MAT), not residential. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at TESTING CENTERs

The care-level question matters because what a facility offers is what it can realistically treat well. TESTING CENTERs is an outpatient-focused program (IOP, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether TESTING CENTERs's offerings match the clinical need.

Insurance and payment

On insurance specifically: TESTING CENTERs accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Specialty programming

The facility's documented specialty programming includes: Adolescents, Adult women, Adult men. The specialty question rewards specific follow-up: what clinicians provide the specialty content, what their credentials are, what percentage of weekly programming is specialty-specific vs. general programming.

Before you call

Three questions to put to TESTING CENTERs before admission: the specific ASAM level the facility is billing; the written Verification of Benefits for your specific plan product; the MAT policy (continuation of buprenorphine or methadone during residential, specifically). The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. Getting answers in writing protects against the downstream surprises.